Advertisement France launches new cell therapy manufacturing facility - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

France launches new cell therapy manufacturing facility

The C4C consortium has implemented France's first ever technical facility to manufacture cell therapy products.

The C4C project coordinated by CELLforCURE is expected to bring together the skills of two biotech companies, seven public-sector organizations and university medical centers.

Five cell therapies are presently being developed by different French universities to dedicate the facility, located on LFB’s site in Les Ulis, France, to the routine production of clinical trial and therapeutic batches.

C4C investment consists of €80m investment from the consortium members and €30m from public-sector financial aid, which was provided by OSEO, France’s state innovation agency.